SA News • Mon, May. 12
There are no Focus articles on LIVR.
There are no Related articles on LIVR.
There are no Transcripts on LIVR.
Mon, May. 12, 7:47 AM
- Shire (SHPG) has acquired San Diego based biopharmaceutical firm Lumena Pharmaceuticals (LIVR) for $260M upfront, as well as a payment for net cash at closing and milestone payments linked to trial results.
- Shire said the deal will add to its portfolio of treatments for rare diseases, with Lumena developing therapies for gastrointestinal problems and liver diseases.
- Lumena had filed to raise as much as $75M in an IPO. (PR)
There are no StockTalks on this stock yet.
LIVR vs. ETF Alternatives
Currently, there's no company description for LIVR.
Country: United States
Other News & PR